Results From The WOW.Com Content Network
COVID-19 vaccination in Indonesia. The COVID-19 vaccination in Indonesia is an ongoing mass immunization in response to the COVID-19 pandemic in Indonesia. On 13 January 2021, the program commenced when President Joko Widodo was vaccinated at the presidential palace. 
Main articles: COVID-19 pandemic in Indonesia, Statistics of the COVID-19 pandemic in Indonesia, and COVID-19 vaccination in Indonesia. Vaccination numbers may not be accurate due to different calculations, cut-off times, and sources from the government. Lower daily inoculations may be recorded on Sundays and public holidays.
www.bpjs-kesehatan.go.id. Badan Penyelenggara Jaminan Sosial Kesehatan (BPJS Kesehatan, lit. 'Social Security Agency on Health') is a social security agency of Indonesia aimed at providing universal health care to its citizens.  BPJS Kesehatan is one of two social security agencies in the country alongside BPJS Ketenagakerjaan [ id] .
Primary care. Primary care may be provided in community health centres. Primary care is the day-to-day healthcare given by a health care provider. Typically this provider acts as the first contact and principal point of continuing care for patients within a healthcare system, and coordinates other specialist care that the patient may need.
The original Bundesprüfstelle für jugendgefährdende Schriften (BPjS, Federal Department for Works Harmful to Young Persons) was established on 18 May 1954, after the Gesetz über die Verbreitung jugendgefährdender Schriften was adopted on 9 June 1953. The presiding officers of the BPjS have been: 1954–1966: Robert Schilling
Louis Pasteur. Louis Pasteur ForMemRS ( / ˈluːi pæˈstɜːr /, French: [lwi pastœʁ]; 27 December 1822 – 28 September 1895) was a French chemist, pharmacist, and microbiologist renowned for his discoveries of the principles of vaccination, microbial fermentation, and pasteurization, the last of which was named after him.
Pneumococcal vaccines Accelerated Development and Introduction Plan (PneumoADIP) is a program to accelerate the evaluation and access to new pneumococcal vaccines in the developing world. PneumoADIP is funded by the Global Alliance for Vaccines and Immunization (GAVI). Thirty GAVI countries have expressed interest in participating by 2010.
Cervarix is a vaccine against certain types of cancer-causing human papillomavirus (HPV). Cervarix is designed to prevent infection from HPV types 16 and 18, that cause about 70% of cervical cancer cases.  These types also cause most HPV-induced genital and head and neck cancers. Additionally, some cross-reactive protection against virus ...